Fraunhofer Institute for Cell Therapy and Immunology IZIGLP Test Facility
Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP).
Zscharnack M, Krause C, Aust G, Thümmler C, Peinemann F, Keller T, Smink JJ, Holland H, Somerson JS, Knauer J, Schulz RM, Lehmann J. J Transl Med. 2015 May 20;13:160. doi: 10.1186/s12967-015-0517-x.
PMID: 25990108
[Strategic considerations on the design and choice of animal models for non-clinical investigations of cell-based medicinal products].
Lehmann J, Schulz RM, Sanzenbacher R. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1215-24. doi: 10.1007/s00103-015-2239-x. German.
PMID: 26431722
Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model.
Pohler P, Lehmann J, Veneruso V, Tomm J, von Bergen M, Lambrecht B, Kohn B, Weingart C, Müller TH, Seltsam A.
Transfusion. 2012 Nov;52(11):2414-26. doi: 10.1111/j.1537-2995.2012.03583.x. Epub 2012 Mar 8.
PMID: 22404822